May 18-21
2025
SCT Annual Meeting Presentations & Videos
* Note that only Keynote Lectures and Trial of the Year are available to non-members for 2022 and 2023.
Members can login to view all presentations from recent years.
* Note that only Keynote Lectures and Trial of the Year are available to non-members for 2022 and 2023.
Members can login to view all presentations from recent years.
Discover SCT's Scientific Knowledge-Bank
330 Learning Opportunities Found
Merit Cudkowicz
2024 (Boston) Annual Meeting
2024 (Boston) Annual Meeting
Curtis Meinert Lecture
Advances in Neurotherapeutics Updates on ALS and NeuroNEXT
Advances in Neurotherapeutics Updates on ALS and NeuroNEXT
Penney Cowan
2024 (Boston) Annual Meeting
2024 (Boston) Annual Meeting
Founders Lecture
Perspective of Those With Lived Experience: Involving a Patient in Clinical Trials
Perspective of Those With Lived Experience: Involving a Patient in Clinical Trials
Adam Devall
2024 (Boston) Annual Meeting
2024 (Boston) Annual Meeting
Trial of the Year Award
Randomized Trial of Early Detection and Treatment of Postpartum Hemorrhage
Randomized Trial of Early Detection and Treatment of Postpartum Hemorrhage
Alan T. Tita
2023 (Baltimore) Annual Meeting
2023 (Baltimore) Annual Meeting
Trial of the Year Award
The Chronic Hypertension and Pregnancy Treatment Trial (CHAP)
The Chronic Hypertension and Pregnancy Treatment Trial (CHAP)
Kirsten Bibbins-Domingo
2023 (Baltimore) Annual Meeting
2023 (Baltimore) Annual Meeting
Founders Lecture
Medical Publishing in Dynamic Times: A View from JAMA and the JAMA Network
Medical Publishing in Dynamic Times: A View from JAMA and the JAMA Network
John P.A. Ioannidis
2023 (Baltimore) Annual Meeting
2023 (Baltimore) Annual Meeting
Curtis Meinert Lecture
Meta-epidemiology of evidence from clinical trials
Meta-epidemiology of evidence from clinical trials
Dong-Yun Kim
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Session Proposal
All for One, One for All: How to Run Multiple Networks of COVID-19 Clinical Trials on a Common Platform Using Bayesian Method
All for One, One for All: How to Run Multiple Networks of COVID-19 Clinical Trials on a Common Platform Using Bayesian Method
Susan Ellenberg
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Session Proposal
Clinical Trials of COVID-19 Vaccines: Overcoming the Challenges
Clinical Trials of COVID-19 Vaccines: Overcoming the Challenges
Min Zhan
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Analysis of Adverse Event and Serious Adverse Event Data from Randomized Controlled Trials
Analysis of Adverse Event and Serious Adverse Event Data from Randomized Controlled Trials
Riaz Qureshi
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Data Visualization Approaches to Presenting Harms in Clinical Trials
Data Visualization Approaches to Presenting Harms in Clinical Trials
Marie Kay
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Assessment of a Risk-Based Quality Management Approach to Protocol Deviations - A Data Coordinating Center's Experience
Assessment of a Risk-Based Quality Management Approach to Protocol Deviations - A Data Coordinating Center's Experience
Eric Fischer
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Dynamically Generating Study Monitoring Reports via Email
Dynamically Generating Study Monitoring Reports via Email
J Athene Lane
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Virtual Clinical Outcome Ascertainment in a Prostate Cancer Treatment Trial
Virtual Clinical Outcome Ascertainment in a Prostate Cancer Treatment Trial
Kelly Karavolos
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Challenges of Data Collection for a Fully Remote Clinical Trial with a Multi-Component Outcome: Virtual ELM Pilot Study
Challenges of Data Collection for a Fully Remote Clinical Trial with a Multi-Component Outcome: Virtual ELM Pilot Study
Rebecca Metcalfe
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Integrating Patient Values into Clinical Trials Using a Patient-Centered Composite Endpoint: A Case Study Using the Control of Hypertension in Pregnancy Study (CHIPS) Trial
Integrating Patient Values into Clinical Trials Using a Patient-Centered Composite Endpoint: A Case Study Using the Control of Hypertension in Pregnancy Study (CHIPS) Trial
BeiBei Guo
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
A Biomarker-Based Dose-Finding Design for Immunotherapy
A Biomarker-Based Dose-Finding Design for Immunotherapy
Yunshan Duan
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
A Unified Decision Framework for Phase I Dose-Finding Designs
A Unified Decision Framework for Phase I Dose-Finding Designs
Hakim-Moulay Dehbi
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Early Phase Dose-Finding Trials in Virology
Early Phase Dose-Finding Trials in Virology
Evan Bagley
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Dose-Finding Based on Feasibility and Late-Onset Toxicity in Adoptive Cell Therapy Trials
Dose-Finding Based on Feasibility and Late-Onset Toxicity in Adoptive Cell Therapy Trials
Jack Wolf
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
A Permutation Procedure to Detect Heterogeneous Treatments Effects in Randomized Clinical Trials While Controlling the Type-I Error Rate
A Permutation Procedure to Detect Heterogeneous Treatments Effects in Randomized Clinical Trials While Controlling the Type-I Error Rate
Peter Godolphin
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Estimating Interactions and Subgroup-Specific Treatment Effects in Meta-Analysis Without Aggregation Bias: A Within-Trial Framework
Estimating Interactions and Subgroup-Specific Treatment Effects in Meta-Analysis Without Aggregation Bias: A Within-Trial Framework
Jiyang Wen
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Simultaneous Hypothesis Testing for Multiple Competing Risks in Comparative Clinical Trials
Simultaneous Hypothesis Testing for Multiple Competing Risks in Comparative Clinical Trials
Andrea Viecelli
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Enhancing Patient-Partnership in Clinical Trials
Enhancing Patient-Partnership in Clinical Trials
Mithat Gönen
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Special Presentation
Annual Business Meeting 2022
Annual Business Meeting 2022
Chalmers & Green Award Presentations
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Award Presentation
Andrea Viecelli, Jiyang Wen, Peter Godolphin, Jack Wolf
Andrea Viecelli, Jiyang Wen, Peter Godolphin, Jack Wolf
Class of 2022 Fellows
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Fellows Presentation
Thomas Cook & Alexia Iasonos
Thomas Cook & Alexia Iasonos
Drs. Edward Mills & Gilmar Reis
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Trial of the Year Award
The TOGETHER Trial: An Adaptive Platform International Trial
The TOGETHER Trial: An Adaptive Platform International Trial
Dr. Robert Califf, FDA Commissioner
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Founders Lecture
The Time is Now to Fix the Evidence Generation System
The Time is Now to Fix the Evidence Generation System
Dr. Worta McCaskill-Stevens
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Curtis Meinert Lecture
Lessons Learned From the National Cancer Institute's Community Based Clinical Trials
Lessons Learned From the National Cancer Institute's Community Based Clinical Trials
Arsenio Paez
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
The Effects of Preceding Prospective Collaborative Studies (IDEAL Stage 2b) on the Quality and Impact of Subsequent Randomized Controlled Trials (IDEAL Stage 3) Evaluating Surgical Innovations: A Systematic Review and Case-Control Study
The Effects of Preceding Prospective Collaborative Studies (IDEAL Stage 2b) on the Quality and Impact of Subsequent Randomized Controlled Trials (IDEAL Stage 3) Evaluating Surgical Innovations: A Systematic Review and Case-Control Study
Annabelle South
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Communicating Overall Results to Trial Participants: The Perspective of Site Staff from the Show RESPECT Study
Communicating Overall Results to Trial Participants: The Perspective of Site Staff from the Show RESPECT Study
Christin Hoffmann
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
A Core Information Set to Guide Early Phase Surgical Research
A Core Information Set to Guide Early Phase Surgical Research
Annabelle South
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Effectiveness of Interventions to Share Trial Results with Health Workers and Policymakers: Results of a Systematic Review
Effectiveness of Interventions to Share Trial Results with Health Workers and Policymakers: Results of a Systematic Review
Zhibao Mi
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Statistical Assessment of Unplanned Crossover Effect in Surgical Trials
Statistical Assessment of Unplanned Crossover Effect in Surgical Trials
Jun Yin
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Multi-Arm Multi-Outcome Clinical Trial Design and Analysis with Bayesian Spike-and-Slab Priors
Multi-Arm Multi-Outcome Clinical Trial Design and Analysis with Bayesian Spike-and-Slab Priors
Daniel Schwartz
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Dynamic Borrowing from Historical Controls via the Synthetic Prior with Covariates in Randomized Clinical Trials
Dynamic Borrowing from Historical Controls via the Synthetic Prior with Covariates in Randomized Clinical Trials
Samuel Sarkodie
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
A Hybrid Approach to Comparing Parallel-Group and Stepped-Wedge Cluster Randomized Trials When There is Uncertainty in the Intra-Cluster Correlation
A Hybrid Approach to Comparing Parallel-Group and Stepped-Wedge Cluster Randomized Trials When There is Uncertainty in the Intra-Cluster Correlation
Clement Ma
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Landscape of Phase 2 Trials in Alzheimer’s Disease: A Systematic Review of Trial Characteristics
Landscape of Phase 2 Trials in Alzheimer’s Disease: A Systematic Review of Trial Characteristics
Christin Hoffmann
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Modifications to Surgical Procedures: A Scoping Review and Preliminary Framework to Promote Transparent Reporting and Efficient Sharing
Modifications to Surgical Procedures: A Scoping Review and Preliminary Framework to Promote Transparent Reporting and Efficient Sharing
Chengwu Yang
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
The CREID: Complementary Randomized Controlled Trial and Real-World Study for Efficacy, Effectiveness, and Implementation Design, with Illustrations of One Published and Two Proposed Large Studies for Sequential and Parallel Designs
The CREID: Complementary Randomized Controlled Trial and Real-World Study for Efficacy, Effectiveness, and Implementation Design, with Illustrations of One Published and Two Proposed Large Studies for Sequential and Parallel Designs
Mark Harrison
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Involving Patients in the Design of Randomized Clinical Trials
Involving Patients in the Design of Randomized Clinical Trials
Caitlin Thomas
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Predicting Patients’ Willingness to Participate in Clinical Trials: A Simulation Tool Using Patient Choice Data
Predicting Patients’ Willingness to Participate in Clinical Trials: A Simulation Tool Using Patient Choice Data
Yun Qing
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
A Bayesian Piecewise Exponential Phase II Design for Monitoring a Time-to-Event Endpoint
A Bayesian Piecewise Exponential Phase II Design for Monitoring a Time-to-Event Endpoint
Yongming Qu
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Collection of Precise Reasons for Treatment Discontinuations to Allow Better Defining Estimands
Collection of Precise Reasons for Treatment Discontinuations to Allow Better Defining Estimands
Mayumi Fukuda-Doi
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Developing At-A-Glance Workflows for Conducting Trials in Compliance with Complex Regulatory Systems and Expectations for Simplification of the System in Japan
Developing At-A-Glance Workflows for Conducting Trials in Compliance with Complex Regulatory Systems and Expectations for Simplification of the System in Japan
Hongli Li
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
A Non-Factorial Analysis of a Factorial Phase II Trial Design to Evaluate Single Agent and Combination Consolidation Therapies Following CD19 CAR T-cell Therapy for Relapsed/Refractory Diffuse Large B cell Lymphoma (R/R DLBCL): SWOG-S2114
A Non-Factorial Analysis of a Factorial Phase II Trial Design to Evaluate Single Agent and Combination Consolidation Therapies Following CD19 CAR T-cell Therapy for Relapsed/Refractory Diffuse Large B cell Lymphoma (R/R DLBCL): SWOG-S2114
Fei Yuan
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Stopping Rules of Interim Monitoring Analyses in Clinical Trials
Stopping Rules of Interim Monitoring Analyses in Clinical Trials
Christin Hoffmann
2022 (San Diego) Annual Meeting
2022 (San Diego) Annual Meeting
Contributed Session
Automated Real-Time Monitoring and Feedback of Shared Decision Making for Surgery: A Non-Randomised Feasibility Study
Automated Real-Time Monitoring and Feedback of Shared Decision Making for Surgery: A Non-Randomised Feasibility Study
Kieran O'Brien
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
The effect of targeting biannual azithromycin distribution by age group on mortality and resistance in Niger: design of an adaptive cluster-randomized large simple trial (AVENIR)
The effect of targeting biannual azithromycin distribution by age group on mortality and resistance in Niger: design of an adaptive cluster-randomized large simple trial (AVENIR)
Emily Rives
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Dynamic Scoring and Guided Data Entry in a Tele-Health Cognitive Battery
Dynamic Scoring and Guided Data Entry in a Tele-Health Cognitive Battery
Gillian Gresham
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Evaluating the effect of a mobile audio companion to reduce feelings of distress and loneliness in cancer patients during COVID-19 (COMPANION Trial)
Evaluating the effect of a mobile audio companion to reduce feelings of distress and loneliness in cancer patients during COVID-19 (COMPANION Trial)
Rachel Phillips
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Recommendations for visualising the drug harm profile in Randomised Controlled Trials: a consensus
Recommendations for visualising the drug harm profile in Randomised Controlled Trials: a consensus
Zibo Tian
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
IMPACT OF UNEQUAL CLUSTER SIZES FOR GENERALIZED ESTIMATING EQUATION ANALYSES OF STEPPED WEDGE DESIGNS WITH BINARY OUTCOMES
IMPACT OF UNEQUAL CLUSTER SIZES FOR GENERALIZED ESTIMATING EQUATION ANALYSES OF STEPPED WEDGE DESIGNS WITH BINARY OUTCOMES
Lindsay Kehoe
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Improving Efficiency by Embedding Trials into Health Care Settings
Improving Efficiency by Embedding Trials into Health Care Settings
Shelley Vanderhout
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
PREVALENCE OF AND FACTORS ASSOCIATED WITH PATIENT-REPORTED OUTCOMES IN PRAGMATIC RANDOMIZED CONTROLLED TRIALS
PREVALENCE OF AND FACTORS ASSOCIATED WITH PATIENT-REPORTED OUTCOMES IN PRAGMATIC RANDOMIZED CONTROLLED TRIALS
Min Zhan
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
CONSIDERATIONS IN IMPLEMENTING THE ESTIMAND FRAMEWORK IN MULTISITE RANDOMIZED CLINICAL TRIALS
CONSIDERATIONS IN IMPLEMENTING THE ESTIMAND FRAMEWORK IN MULTISITE RANDOMIZED CLINICAL TRIALS
Eileen Stock
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
An Efficient Centralized Statistical Monitoring Program to Improve Data Integrity of Multicenter Clinical Trials
An Efficient Centralized Statistical Monitoring Program to Improve Data Integrity of Multicenter Clinical Trials
Neal Oden
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Number of Strata in Clinical Trial Design and Its Impact on Treatment Imbalance
Number of Strata in Clinical Trial Design and Its Impact on Treatment Imbalance
Monica Taljaard
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
HOW ARE CLAIMS OF PRAGMATISM JUSTIFIED IN PRIMARY TRIAL REPORTS? RESULTS FROM A REVIEW OF 415 SELF-DECLARED PRAGMATIC TRIALS
HOW ARE CLAIMS OF PRAGMATISM JUSTIFIED IN PRIMARY TRIAL REPORTS? RESULTS FROM A REVIEW OF 415 SELF-DECLARED PRAGMATIC TRIALS
Ashley Tjaden
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Motivation for participation in a clinical trial among youth and adults with prediabetes or recently diagnosed type 2 diabetes
Motivation for participation in a clinical trial among youth and adults with prediabetes or recently diagnosed type 2 diabetes
Jennifer Gassman
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Use of Vanguard Enrollment to demonstrate feasibility of a high-enrollment surgical trial: The Safe Cholecystectomy OUTcomes (SCOUT) Clinical Trial of Laparoscopic Cholecystectomy (LC)
Use of Vanguard Enrollment to demonstrate feasibility of a high-enrollment surgical trial: The Safe Cholecystectomy OUTcomes (SCOUT) Clinical Trial of Laparoscopic Cholecystectomy (LC)
Holly Shaw
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Centralized Remote and Risk-Based Monitoring in the INVESTED Trial: a Cost-Effective and Easy-to-Implement Approach
Centralized Remote and Risk-Based Monitoring in the INVESTED Trial: a Cost-Effective and Easy-to-Implement Approach
Daniele Farrisi
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Research Ready: Strategies for Successful Implementation of Research in Clinical Settings
Research Ready: Strategies for Successful Implementation of Research in Clinical Settings
Peter McCulloch
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Using IDEAL to evaluate research waste in surgery more realistically.
Using IDEAL to evaluate research waste in surgery more realistically.
Harry Parr
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
DEVELOPING AND VALIDATING CLINICAL DYNAMIC PREDICTION JOINT MODELS TO PREDICT PROGNOSIS IN PROSTATE CANCER PATIENTS
DEVELOPING AND VALIDATING CLINICAL DYNAMIC PREDICTION JOINT MODELS TO PREDICT PROGNOSIS IN PROSTATE CANCER PATIENTS
Paola Berchialla
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Prediction of treatment outcome and heterogeneous treatment effect in clinical trials: a machine learning approach
Prediction of treatment outcome and heterogeneous treatment effect in clinical trials: a machine learning approach
Leah Pirondini
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Covariate adjustment in cardiovascular randomised controlled trials: a review of current practice and simulation studies
Covariate adjustment in cardiovascular randomised controlled trials: a review of current practice and simulation studies
Lara Maleyeff
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Estimating treatment effect heterogeneity in stepped wedge cluster randomized trials with binary outcomes
Estimating treatment effect heterogeneity in stepped wedge cluster randomized trials with binary outcomes
Georgine Price
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
SITE MONITORING AND SITE MANAGEMENT DURING COVID-19 - A CONTRACT RESEARCH ORGANIZATION’S EXPERIENCE
SITE MONITORING AND SITE MANAGEMENT DURING COVID-19 - A CONTRACT RESEARCH ORGANIZATION’S EXPERIENCE
Mitra Lewis
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Electronic Data Capture (EDC) system modifications to capture COVID-19 related data in the National Drug Abuse Treatment Clinical Trial Network (NDAT CTN)
Electronic Data Capture (EDC) system modifications to capture COVID-19 related data in the National Drug Abuse Treatment Clinical Trial Network (NDAT CTN)
Monica Taljaard
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
REPORTING OF INFORMED CONSENT IN PRAGMATIC TRIALS: RESULTS FROM A SYSTEMATIC LITERATURE SURVEY
REPORTING OF INFORMED CONSENT IN PRAGMATIC TRIALS: RESULTS FROM A SYSTEMATIC LITERATURE SURVEY
Dario Gregori
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
The challenge of the COVID-19 pandemic faced by Italian ethics committees: a research survey
The challenge of the COVID-19 pandemic faced by Italian ethics committees: a research survey
Giles Partington
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
The Design and Analysis of Small Population and Rare Disease Trials: A Review of Randomised Trials
The Design and Analysis of Small Population and Rare Disease Trials: A Review of Randomised Trials
Daniel Schwartz
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Fast and Informative Phase 2b Dose-ranging Trials Using Bayesian Uncertainty-Directed Designs with Model Averaging
Fast and Informative Phase 2b Dose-ranging Trials Using Bayesian Uncertainty-Directed Designs with Model Averaging
Emily Roberts
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Incorporating Baseline Covariates to Validate Surrogate Endpoints with a Constant Biomarker under Control Arm
Incorporating Baseline Covariates to Validate Surrogate Endpoints with a Constant Biomarker under Control Arm
Matthew Dodd
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
STATISTICAL METHODS FOR HANDLING NON-ADHERENCE TO INTERVENTIONS IN RANDOMISED NON-INFERIORITY TRIALS: A SYSTEMATIC REVIEW
STATISTICAL METHODS FOR HANDLING NON-ADHERENCE TO INTERVENTIONS IN RANDOMISED NON-INFERIORITY TRIALS: A SYSTEMATIC REVIEW
Victoria Cornelius
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Improving the analysis of adverse event data in randomised controlled trials
Improving the analysis of adverse event data in randomised controlled trials
Matthew Gooden
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Determining the Optimal Percent of Research Records to Review: Reducing the Variability in Audits with Human Research Participants
Determining the Optimal Percent of Research Records to Review: Reducing the Variability in Audits with Human Research Participants
Sharon Love
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Making a distinction between data cleaning and central monitoring
Making a distinction between data cleaning and central monitoring
Lara Philipps
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Study within a trial comparing electronic versus paper patient reported outcome collection
Study within a trial comparing electronic versus paper patient reported outcome collection
Diana Papaioannou
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Adverse event recording fails to reflect potential harms: A review of trial protocols of behavioural, lifestyle and psychological therapy interventions.
Adverse event recording fails to reflect potential harms: A review of trial protocols of behavioural, lifestyle and psychological therapy interventions.
Rebecca Silva
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Would the recommended dose have been different using novel dose-finding designs? Comparing dose-finding designs in published trials.
Would the recommended dose have been different using novel dose-finding designs? Comparing dose-finding designs in published trials.
Xueqi Wang
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Power considerations for generalized estimating equations analyses of four-level designs
Power considerations for generalized estimating equations analyses of four-level designs
Martin Law
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Multi-outcome trials with a generalised number of efficacious outcomes
Multi-outcome trials with a generalised number of efficacious outcomes
Katie Mellor
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
PROGRESSION FROM EXTERNAL PILOT TO DEFINITIVE RANDOMISED CONTROLLED TRIAL ARE NOT ADEQUATELY REPORTED: A METHODOLOGICAL REVIEW OF PROGRESSION CRITERIA REPORTING
PROGRESSION FROM EXTERNAL PILOT TO DEFINITIVE RANDOMISED CONTROLLED TRIAL ARE NOT ADEQUATELY REPORTED: A METHODOLOGICAL REVIEW OF PROGRESSION CRITERIA REPORTING
Christina Fu
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
USE OF COMPREHENSIVE SOLICITED EVENT REPORTING FOR SAFETY MONITORING IN CLINICAL TRIALS WITH STANDARD OF CARE DRUGS
USE OF COMPREHENSIVE SOLICITED EVENT REPORTING FOR SAFETY MONITORING IN CLINICAL TRIALS WITH STANDARD OF CARE DRUGS
Glory Koerbel
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
HOW CLINICAL TRIAL MANAGEMENT SYSTEMS CAN HELP REDUCE COORDINATOR BURDEN
HOW CLINICAL TRIAL MANAGEMENT SYSTEMS CAN HELP REDUCE COORDINATOR BURDEN
Zhibao Mi
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Role of Electronic Health Records in VA CSP Multicenter Clinical Trials
Role of Electronic Health Records in VA CSP Multicenter Clinical Trials
Gail Potter
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Dismantling the Fragility Index: A Demonstration of Statistical Reasoning
Dismantling the Fragility Index: A Demonstration of Statistical Reasoning
Phyllis Goodman
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Actions of a National Oncology Group to Manage the Impact of the COVID-19 Pandemic
Actions of a National Oncology Group to Manage the Impact of the COVID-19 Pandemic
Menelaos Konstantinidis
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
MULTI-AGENT AGREEMENT COEFFICIENTS: IMPLICATIONS FOR CLINICAL TRIALS OF DIAGNOSTIC TESTING
MULTI-AGENT AGREEMENT COEFFICIENTS: IMPLICATIONS FOR CLINICAL TRIALS OF DIAGNOSTIC TESTING
Christin Hoffmann
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
MEASURING INNOVATION-SPECIFIC OUTCOMES IN STUDIES EVALUATING NEW SURGICAL PROCEDURES AND DEVICES: APPRAISAL AND RECOMMENDATION OF OUTCOME MEASUREMENT INSTRUMENTS USING MODIFIED COSMIN METHODOLOGY
MEASURING INNOVATION-SPECIFIC OUTCOMES IN STUDIES EVALUATING NEW SURGICAL PROCEDURES AND DEVICES: APPRAISAL AND RECOMMENDATION OF OUTCOME MEASUREMENT INSTRUMENTS USING MODIFIED COSMIN METHODOLOGY
Douglas Lammie
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Facilitating Study Collaboration in your Pajamas: Replicating a Virtual Office Space While Teleworking"
Facilitating Study Collaboration in your Pajamas: Replicating a Virtual Office Space While Teleworking"
Stuart Nicholls
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
THE IMPACT OF PATIENT ENGAGEMENT ON TRIALS AND TRIALISTS: AN INTERVIEW STUDY WITH IMPACT AWARDEES
THE IMPACT OF PATIENT ENGAGEMENT ON TRIALS AND TRIALISTS: AN INTERVIEW STUDY WITH IMPACT AWARDEES
Gemma Ainsworth
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
CO-ENROLMENT OF PATIENTS IN TRIALS OF COMPLEX SURGICAL INTERVENTIONS: RECOMMENDATIONS FROM THE INTACT TRIAL
CO-ENROLMENT OF PATIENTS IN TRIALS OF COMPLEX SURGICAL INTERVENTIONS: RECOMMENDATIONS FROM THE INTACT TRIAL
Brian Burke
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
From Clinical Trial to Observational Study: Long-Term Retention in the TODAY and TODAY2 Studies
From Clinical Trial to Observational Study: Long-Term Retention in the TODAY and TODAY2 Studies
Saskia Eddy
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
HOW BIG SHOULD MY PILOT STUDY BE? A METHODOLOGICAL REVIEW
HOW BIG SHOULD MY PILOT STUDY BE? A METHODOLOGICAL REVIEW
Ondrej Blaha
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
A Bayesian Exact Platform Design for Multi-arm, Phase II trials with Historical Control
A Bayesian Exact Platform Design for Multi-arm, Phase II trials with Historical Control
Kendra Davis-Plourde
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Sample size calculation for stepped wedge cluster randomized trials with multiple levels of clustering
Sample size calculation for stepped wedge cluster randomized trials with multiple levels of clustering
Brian Burke
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Developing an E-Consent System
Developing an E-Consent System
Alyssa Vanderbeek
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Consequences of Phase I Dose Selection on Go/No-Go Decisions in Oncology Drug Development
Consequences of Phase I Dose Selection on Go/No-Go Decisions in Oncology Drug Development
Mitchell Paukner
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Window Mean Survival Time
Window Mean Survival Time
J Athene Lane
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
PATIENT AND PUBLIC INVOLVEMENT IN CLINICAL TRIALS: A MIXED METHODS STUDY IN A CLINICAL TRIALS UNIT TO IDENTIFY GOOD PRACTICE, BARRIERS AND FACILITATORS
PATIENT AND PUBLIC INVOLVEMENT IN CLINICAL TRIALS: A MIXED METHODS STUDY IN A CLINICAL TRIALS UNIT TO IDENTIFY GOOD PRACTICE, BARRIERS AND FACILITATORS
Madeleine Clout
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Are Electronic Study Management Systems Acceptable to Participating Sites?
Are Electronic Study Management Systems Acceptable to Participating Sites?
Amy Sullivan
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
What is the (end) point?
What is the (end) point?
Joerg Hasford
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
There are too many p-values smaller 0.01 for clinically relevant primary endpoints reported in randomised trials - results from a systematic analysis of high impact publications
There are too many p-values smaller 0.01 for clinically relevant primary endpoints reported in randomised trials - results from a systematic analysis of high impact publications
Dario Gregori
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
The state-of-the-art of the Prior Elicitation method in clinical trial design and analysis: a literature review
The state-of-the-art of the Prior Elicitation method in clinical trial design and analysis: a literature review
Christopher Schroth
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
The Record of Study Consultation (RSC): A Tool to Control, Document, & Streamline Sponsor Guidance
The Record of Study Consultation (RSC): A Tool to Control, Document, & Streamline Sponsor Guidance
Sheila Sprague
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
THE IMPACT OF COVID-19 RESTRICTIONS ON PARTICIPANT ENROLLMENT IN THE PREPARE TRIAL
THE IMPACT OF COVID-19 RESTRICTIONS ON PARTICIPANT ENROLLMENT IN THE PREPARE TRIAL
Mudathir Ibrahim
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
The effects of preceding prospective collaborative studies (IDEAL stage 2b) on the quality and impact of subsequent randomized controlled trials (IDEAL stage 3) evaluating surgical innovations. A case-control systematic review of the literature
The effects of preceding prospective collaborative studies (IDEAL stage 2b) on the quality and impact of subsequent randomized controlled trials (IDEAL stage 3) evaluating surgical innovations. A case-control systematic review of the literature
David Zahrieh
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Symbolic two-step method compared with single-step methods to model the center mean outcome in cluster randomized trials
Symbolic two-step method compared with single-step methods to model the center mean outcome in cluster randomized trials
Wei Wei
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Summarizing historical information for making go/no go decisions in phase II clinical trials
Summarizing historical information for making go/no go decisions in phase II clinical trials
Subodh Selukar
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
STRATIFIED RANDOMIZATION FOR PLATFORM TRIALS WITH DIFFERING EXPERIMENTAL ARM ELIGIBILITY
STRATIFIED RANDOMIZATION FOR PLATFORM TRIALS WITH DIFFERING EXPERIMENTAL ARM ELIGIBILITY
Sasha Kravets
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
STATISTICAL CONSIDERATIONS FOR SEQUENTIAL, MULTIPLE ASSIGNMENT, RANDOMIZED TRIALS
STATISTICAL CONSIDERATIONS FOR SEQUENTIAL, MULTIPLE ASSIGNMENT, RANDOMIZED TRIALS
Leslie Revoredo
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Responsible Tracking and Accounting of Participant Mental Health Urgency/Emergency Responses in Substance Use Treatment Clinical Trials
Responsible Tracking and Accounting of Participant Mental Health Urgency/Emergency Responses in Substance Use Treatment Clinical Trials
Yuanxi Jia
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Redundant Clinical Trials Are Hurting Patients An Example of Randomized Clinical Trials Conducted in mainland China Evaluating Statins among Patients with Coronary Artery Disease
Redundant Clinical Trials Are Hurting Patients An Example of Randomized Clinical Trials Conducted in mainland China Evaluating Statins among Patients with Coronary Artery Disease
Kimberly Carlson
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
PTXRx Study: How Pragmatic Trial Design can Inoculate Against Risks to Study Integrity in a Global Pandemic
PTXRx Study: How Pragmatic Trial Design can Inoculate Against Risks to Study Integrity in a Global Pandemic
David Zahrieh
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Prediction of participant satisfaction in cancer chemoprevention clinical trials using random forests
Prediction of participant satisfaction in cancer chemoprevention clinical trials using random forests
Alyssa Vanderbeek
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Platform trials take the spotlight in COVID-19
Platform trials take the spotlight in COVID-19
Tao Wang
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
PHASE I CAR-T CLINICAL TRIALS REVIEW
PHASE I CAR-T CLINICAL TRIALS REVIEW
Christin Hoffmann
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
A CORE OUTCOME SET FOR STANDARDIZING AND REPORTING SURGICAL INNOVATION: RESULTS OF AN INTERNATIONAL DELPHI SURVEY AND CONSENSUS MEETING
A CORE OUTCOME SET FOR STANDARDIZING AND REPORTING SURGICAL INNOVATION: RESULTS OF AN INTERNATIONAL DELPHI SURVEY AND CONSENSUS MEETING
Radhika Kondapaka
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
LEVERAGING PATIENT PROFILES FOR ROUTINE PHARMACOVIGILANCE IN CLINICAL TRIALS
LEVERAGING PATIENT PROFILES FOR ROUTINE PHARMACOVIGILANCE IN CLINICAL TRIALS
Sharone Edelstein
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Lessons learned from The Restoring Insulin Secretion (RISE) Study: A multi-protocol, multi-center clinical trial in adults and youth with prediabetes and early type 2 diabetes
Lessons learned from The Restoring Insulin Secretion (RISE) Study: A multi-protocol, multi-center clinical trial in adults and youth with prediabetes and early type 2 diabetes
Danila Azzolina
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
How informative is informative in small size trials: a simulation study
How informative is informative in small size trials: a simulation study
Victoria Homer
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
GUIDELINES FOR THE CONTENT OF STATISTICAL ANALYSIS PLANS FOR EARLY PHASE CLINICAL TRIALS
GUIDELINES FOR THE CONTENT OF STATISTICAL ANALYSIS PLANS FOR EARLY PHASE CLINICAL TRIALS
Liyun Jiang
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Elastic Priors to Dynamically Borrow Information from Historical Data in Clinical Trials
Elastic Priors to Dynamically Borrow Information from Historical Data in Clinical Trials
Kathryn Evans
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Discriminant validity of the Misuse, Abuse, and Diversion Drug Event Reporting System (MADDERS) in adult and pediatric phase II and III clinical trials
Discriminant validity of the Misuse, Abuse, and Diversion Drug Event Reporting System (MADDERS) in adult and pediatric phase II and III clinical trials
Kathryn Hefner
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Development of a COVID-19 Impact Assessment for National Drug Abuse Treatment (NDAT) Clinical Trials Network (CTN)
Development of a COVID-19 Impact Assessment for National Drug Abuse Treatment (NDAT) Clinical Trials Network (CTN)
Marcus Johnson
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Development and Implementation of Work Engagement Strategies in a Clinical Research Consortium During the Coronavirus Disease 2019 (COVID-19) Pandemic
Development and Implementation of Work Engagement Strategies in a Clinical Research Consortium During the Coronavirus Disease 2019 (COVID-19) Pandemic
Siyun Yang
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Covariate adjustment in subgroup analyses of randomized clinical trials: A propensity score approach
Covariate adjustment in subgroup analyses of randomized clinical trials: A propensity score approach
Fei Yuan
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Cost-Effectiveness analysis of cardiac versus non-cardiac surgery on cardiovascular-disease population
Cost-Effectiveness analysis of cardiac versus non-cardiac surgery on cardiovascular-disease population
Xiaoyu Tang
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Bayesian multivariate network meta-analysis model for the difference in restricted mean survival times
Bayesian multivariate network meta-analysis model for the difference in restricted mean survival times
Andrea Marraffino
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Automated, customized, patient-centric performance feedback in clinical trials to improve data accuracy and patient compliance
Automated, customized, patient-centric performance feedback in clinical trials to improve data accuracy and patient compliance
Shun Fu Lee
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Analysis for cluster-randomized crossover trials with multiple periods.
Analysis for cluster-randomized crossover trials with multiple periods.
Bryan Nelson
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
An Examination of Methods for Parameter Estimation Following Adaptive Group Sequential Clinical Trials
An Examination of Methods for Parameter Estimation Following Adaptive Group Sequential Clinical Trials
Wen Zhang
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
A Bayesian group sequential design for randomized biosimilar clinical trials with adaptive information borrowing from historical data
A Bayesian group sequential design for randomized biosimilar clinical trials with adaptive information borrowing from historical data
Qilu Yu
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
Managing Pragmatic Clinical Trials in the Time of COVID-19
Managing Pragmatic Clinical Trials in the Time of COVID-19
Zachary Hallinan
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Educational Session
Accelerating evidence generation through quality by design
Accelerating evidence generation through quality by design
Stefan Englert
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Educational Session
How the estimand addendum to the ICH E9 guideline helps structure clinical objectives, analyses, and conclusions – a series of oncology case studies
How the estimand addendum to the ICH E9 guideline helps structure clinical objectives, analyses, and conclusions – a series of oncology case studies
Audrey Mauguen
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
THE TRUE POWER OF CLINICAL TRIALS IN PEDIATRIC CANCERS AND OTHER RARE DISEASES
THE TRUE POWER OF CLINICAL TRIALS IN PEDIATRIC CANCERS AND OTHER RARE DISEASES
Lauren Balmert
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
Operational Innovations in Academic Data Analysis and Coordinating Centers
Operational Innovations in Academic Data Analysis and Coordinating Centers
Thomas Cook
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
Missing Data in Clinical Trials: principles, planning, prevention
Missing Data in Clinical Trials: principles, planning, prevention
Lehana Thabane
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
Design and conduct of pilot and feasibility trials: focus on unresolved issues
Design and conduct of pilot and feasibility trials: focus on unresolved issues
Rema Raman
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
Impact of the COVID-19 Pandemic on the Design, Operations and Analysis Plans of Dementia Trials
Impact of the COVID-19 Pandemic on the Design, Operations and Analysis Plans of Dementia Trials
The RECOVERY Collaborative Group
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Trial of the Year Award
RECOVERY - Randomised Evaluation of COVID-19 Therapy
RECOVERY - Randomised Evaluation of COVID-19 Therapy
Yves Rosenberg
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Educational Session
Essentials of Clinical Trials
Essentials of Clinical Trials
Anna Heath
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Educational Session
Designing Clinical Research to Inform Decision-Making using Value of Information
Designing Clinical Research to Inform Decision-Making using Value of Information
Susan Halabi, Domenic Reda, Li Chen,
Liz Garrett-Mayer, Mithat Gönen, Colin Begg
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Special Presentation
Annual Business Meeting 2021
Annual Business Meeting 2021
J. Jack Lee, 2021 SCT Fellows
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Fellows Presentation
Presentation of the Class of 2021 Fellows
Presentation of the Class of 2021 Fellows
Pralay Mukhopadhyay
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
Challenges with COVID-19 Vaccine Development and Assessing Impact of the Pandemic on Oncology Trial Outcomes
Challenges with COVID-19 Vaccine Development and Assessing Impact of the Pandemic on Oncology Trial Outcomes
Darren Courtney
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
Choices, choices: Selecting, defining, and measuring outcomes for young people with depressive disorders
Choices, choices: Selecting, defining, and measuring outcomes for young people with depressive disorders
Holly Janes
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
Current issues in the design and analysis of COVID-19 vaccine efficacy trials
Current issues in the design and analysis of COVID-19 vaccine efficacy trials
Dee Blumberg
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
Challenges and Best Practices for Recruitment and Retention During the COVID Pandemic
Challenges and Best Practices for Recruitment and Retention During the COVID Pandemic
James Wason
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Costs and Staffing Resource Requirements for Adaptive Trials: results from the Costing Adaptive Trials (CAT) Project
Costs and Staffing Resource Requirements for Adaptive Trials: results from the Costing Adaptive Trials (CAT) Project
Beatriz Goulao
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Patient and public involvement in numerical aspects of trials: a theory-informed survey of trialists current practices, barriers and facilitators
Patient and public involvement in numerical aspects of trials: a theory-informed survey of trialists current practices, barriers and facilitators
Yumin Wang
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Design and analysis of partially randomized preference trials with propensity score stratification
Design and analysis of partially randomized preference trials with propensity score stratification
Xinyu Tang
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
The Use of Conditional Power in Vaccine Trials with Seasonal Variations
The Use of Conditional Power in Vaccine Trials with Seasonal Variations
Laura Levit
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
It Can Be Done! Equitable, Accessible, and Efficient Clinical Trials Through Streamlined Protocol Designs and Requirements
It Can Be Done! Equitable, Accessible, and Efficient Clinical Trials Through Streamlined Protocol Designs and Requirements
Chen Hu
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
recent developments in quantitative benefit-risk assessment in clinical trials
recent developments in quantitative benefit-risk assessment in clinical trials
Tyler Bonnett
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
Design and Implementation of Clinical Trials in a Pandemic – Reflecting on the ACTT Studies
Design and Implementation of Clinical Trials in a Pandemic – Reflecting on the ACTT Studies
Hayley Belli
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Guidelines regarding the enrollment of patients and evidence from Expanded Access programs: A case study of convalescent plasma therapy for the treatment of COVID-19
Guidelines regarding the enrollment of patients and evidence from Expanded Access programs: A case study of convalescent plasma therapy for the treatment of COVID-19
Alice Faust
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Challenges and proposed solutions in making clinical research on COVID-19 ethical. A status quo analysis across German research ethics committees
Challenges and proposed solutions in making clinical research on COVID-19 ethical. A status quo analysis across German research ethics committees
Jody Ciolino
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Making interim decisions using conditional power based on a surrogate endpoint
Making interim decisions using conditional power based on a surrogate endpoint
Arsenio Paez
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Intervention fidelity and treatment effect estimates in clinical trials of complex interventions: A meta-epidemiological study.
Intervention fidelity and treatment effect estimates in clinical trials of complex interventions: A meta-epidemiological study.
Susan Halabi
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
SCT New Committees and DMC Training Initiative
SCT New Committees and DMC Training Initiative
Monica Taljaard
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
Pragmatic trials: key unresolved ethical issues and the need for guidance
Pragmatic trials: key unresolved ethical issues and the need for guidance
Janel Fedler
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
The Impact of COVID-19 on the Conduct of Trials in the NeuroNEXT Network
The Impact of COVID-19 on the Conduct of Trials in the NeuroNEXT Network
Kert Viele
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
Bayesian Modeling in COVID-19 – Disease Modeling, Therapeutics, and Vaccines
Bayesian Modeling in COVID-19 – Disease Modeling, Therapeutics, and Vaccines
Julissa Almonte Santana
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Web-Based Lab Tracking for Lab Blood Data Collection and Shipping Manifest Creation
Web-Based Lab Tracking for Lab Blood Data Collection and Shipping Manifest Creation
Jennifer Le-Rademacher
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Adverse Event Burden Score—A Versatile Summary Measure for Cancer Clinical Trials
Adverse Event Burden Score—A Versatile Summary Measure for Cancer Clinical Trials
Susan Halabi
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
On the Design of Stratified Biomaker Trials with Measurement Error
On the Design of Stratified Biomaker Trials with Measurement Error
Subodh R. Selukar, Siyun Yang, Xiaoyu Tang
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Award Presentation
Thomas C. Chalmers Scholarship Finalists
Thomas C. Chalmers Scholarship Finalists
Lehana Thabane
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
INCREASING DIVERSITY IN CARDIOVASCULAR CLINICAL TRIALS: ENGAGEMENT, RECRUITMENT, LEADERSHIP
INCREASING DIVERSITY IN CARDIOVASCULAR CLINICAL TRIALS: ENGAGEMENT, RECRUITMENT, LEADERSHIP
Jonathan Cook
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
The ASPIRE guidance on surgical placebo controls in randomised trials
The ASPIRE guidance on surgical placebo controls in randomised trials
Erinn Hade
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
Sample size re-estimation: Reflections on implementation and extensions to complex designs
Sample size re-estimation: Reflections on implementation and extensions to complex designs
Ashley Wegel
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
Adaptive COVID-19 Treatment Trial (ACTT) Data Management: Ensuring Success in a Constantly-Evolving, High-Demand Pandemic Environment
Adaptive COVID-19 Treatment Trial (ACTT) Data Management: Ensuring Success in a Constantly-Evolving, High-Demand Pandemic Environment
Sheng Luo
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Educational Session
Design Clinical Trials with Multiple Endpoints: Methods and Applications
Design Clinical Trials with Multiple Endpoints: Methods and Applications
Martin Landray
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Curtis Meinert Lecture
Better Trials for Better Health
Better Trials for Better Health
Susan Halabi
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Educational Session
Biomarker Driven Trials for Precision Medicine
Biomarker Driven Trials for Precision Medicine
Jody Ciolino, SCT Membership Committee
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Special Presentation
New Member Welcome & Orientation
New Member Welcome & Orientation
Greg Ball
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
Different Clinical Trial Analyses for Different Stakeholders
Different Clinical Trial Analyses for Different Stakeholders
Saurabh Mukhopadhyay
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
Leveraging External Evidence in Clinical Research using Novel Statistical Methods
Leveraging External Evidence in Clinical Research using Novel Statistical Methods
Shahrul Mt-Isa
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
Benefit-Risk Assessment in Clinical Trials with Individual Patient Needs in Mind
Benefit-Risk Assessment in Clinical Trials with Individual Patient Needs in Mind
James Albert
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
Design and Implementation of a Vaccine Trial in a Pandemic – mRNA-1273 Phase I Trial
Design and Implementation of a Vaccine Trial in a Pandemic – mRNA-1273 Phase I Trial
Nikki Totton
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Contributed Session
Utilising Benefit-Risk Assessments within Clinical Trials
Utilising Benefit-Risk Assessments within Clinical Trials
Sonia Jain
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
Design, Implementation, and Analysis of N-of-1 Clinical Trials
Design, Implementation, and Analysis of N-of-1 Clinical Trials
Charles Weijer
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Session Proposal
Ethics and future of human challenge trials with SARS-CoV-2 to speed vaccine development
Ethics and future of human challenge trials with SARS-CoV-2 to speed vaccine development
Cliff Lane
2021 (Virtual) Annual Meeting
2021 (Virtual) Annual Meeting
Founders Lecture
Conducting Clinical Research in the Setting of an Outbreak: From HIV to Ebola to COVID-19
Conducting Clinical Research in the Setting of an Outbreak: From HIV to Ebola to COVID-19
Dikla Blumberg
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Session Proposal
Strategies to Collaboratively Manage Protocol Deviations in Multi-Site Clinical Trials
Strategies to Collaboratively Manage Protocol Deviations in Multi-Site Clinical Trials
Amy Ruppert Stark
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Session Proposal
The design and implementation of Master Protocols using examples from oncology clinical trials.
The design and implementation of Master Protocols using examples from oncology clinical trials.
Simon Bacon
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Session Proposal
Methodological advances in the conduct of behavioral clinical trials: An International Behavioural Trials Network (IBTN) update.
Methodological advances in the conduct of behavioral clinical trials: An International Behavioural Trials Network (IBTN) update.
Lu Mao Mao
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Session Proposal
The win ratio approach to composite endpoints
The win ratio approach to composite endpoints
Brooke Erchinger
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Educational Session
Using meta-analysis to combine results from clinical trials
Using meta-analysis to combine results from clinical trials
Susan Czajkowski
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Educational Session
From Ideas to Efficacy: Designing & Optimizing Behavioral Treatments for Chronic Diseases
From Ideas to Efficacy: Designing & Optimizing Behavioral Treatments for Chronic Diseases
Cody Chiuzan
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Educational Session
Web-based applications for early-phase trials designs
Web-based applications for early-phase trials designs
Michael Rosenblum
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Session Proposal
Adjusting for Prognostic Baseline Variables to Improve Precision and Power in Randomized Trials
Adjusting for Prognostic Baseline Variables to Improve Precision and Power in Randomized Trials
Elizabeth Wright
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Session Proposal
Management and Sharing of Individual Participant Deidentified Data (IPD)
Management and Sharing of Individual Participant Deidentified Data (IPD)
Andrew Embleton-Thirsk
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Contrasting case-studies of non-commercial trials being used as a pivotal evidence in licencing submissions to the European Medicines Agency
Contrasting case-studies of non-commercial trials being used as a pivotal evidence in licencing submissions to the European Medicines Agency
Meredith Warshaw
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
IMPAACT 2016: Interdisciplinary Collaboration at Multiple Levels
IMPAACT 2016: Interdisciplinary Collaboration at Multiple Levels
Jason Kojtek
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Building a drug management system
Building a drug management system
Susan Halabi, Mithat Gönen
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Fellows Presentation
Presentation of the Class of 2020 Fellows
Presentation of the Class of 2020 Fellows
Levent Bayman
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Real-Time Risk-Based Monitoring in Clinical Trials Using Business Intelligence Tools (Unlikely Companions)
Real-Time Risk-Based Monitoring in Clinical Trials Using Business Intelligence Tools (Unlikely Companions)
Levent Bayman
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Transition From Two Phase 3 Clinical Trials To A Reduced Follow-Up Only Trial
Transition From Two Phase 3 Clinical Trials To A Reduced Follow-Up Only Trial
Deborah Zarin
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Addressing Challenges in Registering and Reporting Results for Master Protocol Studies
Addressing Challenges in Registering and Reporting Results for Master Protocol Studies
Anna Heath
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
A Bayesian Continual Reassessment Design for a Dose Ranging Study of Intranasal Dexmedetomidine for Paediatric Laceration Repair
A Bayesian Continual Reassessment Design for a Dose Ranging Study of Intranasal Dexmedetomidine for Paediatric Laceration Repair
Anna Heath
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
The KidsCAN-PERC Innovative Paediatric Clinical Trials Network (iPCT): An Interdisciplinary Approach to Clinical Trials Methodology.
The KidsCAN-PERC Innovative Paediatric Clinical Trials Network (iPCT): An Interdisciplinary Approach to Clinical Trials Methodology.
Anna Heath
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Determining a Bayesian Predictive Power Stopping Rule for Futility in a Non-Inferiority Trial with Binary Outcomes: The INK trial
Determining a Bayesian Predictive Power Stopping Rule for Futility in a Non-Inferiority Trial with Binary Outcomes: The INK trial
Chris Rogers
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Automation of clinical trial statistical monitoring
Automation of clinical trial statistical monitoring
Danila Azzolina
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Bayesian HPD-based sample sizedetermination using semi-parametric prior elicitation
Bayesian HPD-based sample sizedetermination using semi-parametric prior elicitation
Daniele Bottigliengo
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Central Statistical Data Quality Monitoring in Clinical Studies: an application to the ROLEX registry
Central Statistical Data Quality Monitoring in Clinical Studies: an application to the ROLEX registry
Danila Azzolina
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Bayesian methods to cope with poor accrual in pediatric trials
Bayesian methods to cope with poor accrual in pediatric trials
Kelly Folkers
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Data from Expanded Access: Opportunity for Real World Evidence Collection and Insights?
Data from Expanded Access: Opportunity for Real World Evidence Collection and Insights?
Fuad Abujarad
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Comparing a Multimedia Interactive Virtual Informed Consent (VIC) to Traditional Paper-based Method: A randomized Clinical Trial
Comparing a Multimedia Interactive Virtual Informed Consent (VIC) to Traditional Paper-based Method: A randomized Clinical Trial
Ilaria Domenicano
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Determining mental health condition patterns in Veterans with a lifetime PTSD diagnosis
Determining mental health condition patterns in Veterans with a lifetime PTSD diagnosis
Grecio Sandoval
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Cost-Efficient Clinical Studies with Continuous Time-to-Event Outcomes
Cost-Efficient Clinical Studies with Continuous Time-to-Event Outcomes
Jessica Guyer
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Clinical Trial Design, Protocol Implementation, and Secular Treatment Trends for Persons Living with HIV and Opioid Use Disorder: Lessons Learned from a National Institute on Drug Abuse Clinical Trials Network (CTN) Trial
Clinical Trial Design, Protocol Implementation, and Secular Treatment Trends for Persons Living with HIV and Opioid Use Disorder: Lessons Learned from a National Institute on Drug Abuse Clinical Trials Network (CTN) Trial
Fei Yuan
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
The Association between Genotypes and Post Cardiac Surgery Bleedings: A substudy of the Steroids in Cardiac Surgery Trial (SIRS)
The Association between Genotypes and Post Cardiac Surgery Bleedings: A substudy of the Steroids in Cardiac Surgery Trial (SIRS)
Lucy Culliford
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Do study participants complete electronic questionnaires?
Do study participants complete electronic questionnaires?
Shray Alag
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Extracting Unique Insights by Mining Single Nucleotide Polymorphisms (SNPs) from ClinicalTrials.gov and Applying the Human Phenotype Ontology
Extracting Unique Insights by Mining Single Nucleotide Polymorphisms (SNPs) from ClinicalTrials.gov and Applying the Human Phenotype Ontology
Rick Mitchell
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Ensuring Consistency Across CDISC Dataset Programming Processes
Ensuring Consistency Across CDISC Dataset Programming Processes
Daniel Kang
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Efficient Bayesian Adaptive Design for Oncology Clinical Trials with Multiple Biomarker Subgroups
Efficient Bayesian Adaptive Design for Oncology Clinical Trials with Multiple Biomarker Subgroups
Nora Hutchinson
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
How Many Patients Does It Take to Develop a New Cancer Drug? A Cohort Study of Pre-license Oncology Drugs
How Many Patients Does It Take to Develop a New Cancer Drug? A Cohort Study of Pre-license Oncology Drugs
Jonathan Walsh
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Improving Clinical Trial Efficiency Using Machine Learning Models of Disease Progression
Improving Clinical Trial Efficiency Using Machine Learning Models of Disease Progression
Russell Thirard
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Integrating expert opinions with clinical trial data to increase power to detect a treatment effect in subgroups: example of a Bayesian analysis of the VeRDiCT trial
Integrating expert opinions with clinical trial data to increase power to detect a treatment effect in subgroups: example of a Bayesian analysis of the VeRDiCT trial
Chris Rogers
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Instrumental variable methods for assessing the causal effect of an intervention in the presence of differential non-adherence; application to the AIRWAYS-2 trial
Instrumental variable methods for assessing the causal effect of an intervention in the presence of differential non-adherence; application to the AIRWAYS-2 trial
Yuanyuan Lu
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
How Big is a Big Hazard Ratio in Clinical Trials?
How Big is a Big Hazard Ratio in Clinical Trials?
Dikla Blumberg
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Session Proposal
Regulatory considerations for a multi-site clinical trial treating opioid use disorder (OUD) with vulnerable populations: pregnant women, infants, and potential prisoners
Regulatory considerations for a multi-site clinical trial treating opioid use disorder (OUD) with vulnerable populations: pregnant women, infants, and potential prisoners
Yue Song
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Random-effects meta-analysis of combined outcomes based on reconstructions of individual patient data
Random-effects meta-analysis of combined outcomes based on reconstructions of individual patient data
Kristina Lindsley
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Public availability of clinical trial results from a random sample of systematic reviews
Public availability of clinical trial results from a random sample of systematic reviews
Matthew Gooden
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
The Impact of Site Initiation Visits on Non Compliance in Neurology Research
The Impact of Site Initiation Visits on Non Compliance in Neurology Research
Alicia Williams
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
The Impact of Different Missing Data Imputation Methods: a case study using the Veterans Affairs Nephropathy in Diabetes (VA NEPHRON-D) Study
The Impact of Different Missing Data Imputation Methods: a case study using the Veterans Affairs Nephropathy in Diabetes (VA NEPHRON-D) Study
Alisa Stephens-Shields
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Simulation-based Design of Pragmatic Trials in Psoriatic Arthritis Using Propensity Scores
Simulation-based Design of Pragmatic Trials in Psoriatic Arthritis Using Propensity Scores
Rouba Chahine
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Sample Size Methods for Two-Stage Randomized Trials with Time to Event Data
Sample Size Methods for Two-Stage Randomized Trials with Time to Event Data
Isabelle Weir
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Counterfactual mediation analysis with multistate models for surrogate and clinical time-to-event outcomes
Counterfactual mediation analysis with multistate models for surrogate and clinical time-to-event outcomes
Victoria Trapani
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Vital Status Ascertainment in a Long-Term Clinical Study of Type 1 Diabetes
Vital Status Ascertainment in a Long-Term Clinical Study of Type 1 Diabetes
Wendi Liang
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Using Results from a Natural History Study to Reduce Patient Burden in Later Clinical Trials
Using Results from a Natural History Study to Reduce Patient Burden in Later Clinical Trials
Phoebe Gauthier
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Using an Interdisciplinary Approach to Develop a Medical Record Abstraction and Quality Assurance Process for Generating the Primary Outcome in a Multi-Site Implementation Study
Using an Interdisciplinary Approach to Develop a Medical Record Abstraction and Quality Assurance Process for Generating the Primary Outcome in a Multi-Site Implementation Study
Deborah Profit, PhD
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
The Value Proposition of eConsent in Clinical Trials
The Value Proposition of eConsent in Clinical Trials
Catherine Houghton
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Potential participants’ views on the factors that impact on their decision to take part in a randomised trial: A qualitative evidence synthesis.
Potential participants’ views on the factors that impact on their decision to take part in a randomised trial: A qualitative evidence synthesis.
Patricia Vanderwolf
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Patient-Focused Research on Metachromatic Leukodystrophy
Patient-Focused Research on Metachromatic Leukodystrophy
Richard Hooper
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Optimal incomplete designs for stepped wedge trials in continuous time
Optimal incomplete designs for stepped wedge trials in continuous time
Anna Heath
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Adaptive Seamless Phase II/III Design for the Ketodex trial
Adaptive Seamless Phase II/III Design for the Ketodex trial
Jiyu Kim
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Analysis of multicenter clinical trials with very low event rates
Analysis of multicenter clinical trials with very low event rates
ASM Borhan
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
Analysis and reporting of data from stratified cluster randomized trials – a systematic survey
Analysis and reporting of data from stratified cluster randomized trials – a systematic survey
Emily Hite
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
An examination of treatment interventions for glioblastoma multiforme and its affect on patient withdrawals/drop outs
An examination of treatment interventions for glioblastoma multiforme and its affect on patient withdrawals/drop outs
Guilherme Lopes
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Contributed Session
A novel method of reporting adverse effects in cancer clinical trials.
A novel method of reporting adverse effects in cancer clinical trials.
Student finalists presenting their papers and the winner announced live during the webinar!
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Award Presentation
Thomas C. Chalmers Student Scholarship
Thomas C. Chalmers Student Scholarship
Jean-Jacques Muyembe-Tamfum, Lori Dodd, Oliver Tshiani Mbala, and Jamila Adoulhab
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Trial of the Year Award
Pamoja Tulinde Maisha (PALM ["Together Save Lives"] in the Kiswahili language) trial
Pamoja Tulinde Maisha (PALM ["Together Save Lives"] in the Kiswahili language) trial
SCT President, Officers and Committee Chairs
2020 (Virtual) Annual Meeting
2020 (Virtual) Annual Meeting
Special Presentation
Annual Business Meeting 2020
Annual Business Meeting 2020
Various Speakers
2019 (New Orleans) Annual Meeting
2019 (New Orleans) Annual Meeting
Special Presentation
Special Founders Session
Special Founders Session
James J. Dignam & Letitia Perdue
2019 (New Orleans) Annual Meeting
2019 (New Orleans) Annual Meeting
Award Presentation
Thomas C. Chalmers Scholarship, Sylvan Green & Poster Awards
Thomas C. Chalmers Scholarship, Sylvan Green & Poster Awards
Dr. Monica Bertagnolli
2019 (New Orleans) Annual Meeting
2019 (New Orleans) Annual Meeting
Founders Lecture
Building a learning health care system, and learning from every patient
Building a learning health care system, and learning from every patient
Susan Halabi
2019 (New Orleans) Annual Meeting
2019 (New Orleans) Annual Meeting
Fellows Presentation
Presentation of the Class of 2019 Fellows
Presentation of the Class of 2019 Fellows
Dr. Lynette Keyes-Elstein
2019 (New Orleans) Annual Meeting
2019 (New Orleans) Annual Meeting
Trial of the Year Award
The Scleroderma: Cyclophosphamide or Transplantation (SCOT) trial
The Scleroderma: Cyclophosphamide or Transplantation (SCOT) trial
Sumithra Mandrekar
2019 (New Orleans) Annual Meeting
2019 (New Orleans) Annual Meeting
Presidential Welcome
Clinical Trials: A Catalyst for Societal Advancement through Innovation
Clinical Trials: A Catalyst for Societal Advancement through Innovation
Thomas Fleming
2019 (New Orleans) Annual Meeting
2019 (New Orleans) Annual Meeting
Curtis Meinert Lecture
Striving to achieve and protect the integrity of clinical trials
Striving to achieve and protect the integrity of clinical trials
Mahesh Parmar
2018 (Portland) Annual Meeting
2018 (Portland) Annual Meeting
Trial of the Year Award
The Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE, NCT00268476)
The Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE, NCT00268476)
Fan-fan Yu, Kathleen Reape
2018 (Portland) Annual Meeting
2018 (Portland) Annual Meeting
Trial of the Year Award
Efficacy and Safety of Voretigene Neparvovec (AAV2-hRPE65v2) in Patients with RPE65-mediated Inherited Retinal Dystrophy
Efficacy and Safety of Voretigene Neparvovec (AAV2-hRPE65v2) in Patients with RPE65-mediated Inherited Retinal Dystrophy
William C. Cushman
2018 (Portland) Annual Meeting
2018 (Portland) Annual Meeting
Founders Lecture
Major VA and NHLBI Clinical Trials That Impacted the Management of Hypertension
Major VA and NHLBI Clinical Trials That Impacted the Management of Hypertension
Susan Halabi
2018 (Portland) Annual Meeting
2018 (Portland) Annual Meeting
Fellows Presentation
Presentation of the Class of 2018 Fellows
Presentation of the Class of 2018 Fellows
James J. Dignam
2018 (Portland) Annual Meeting
2018 (Portland) Annual Meeting
Award Presentation
Thomas C. Chalmers Scholarship and Sylvan Green Awards
Thomas C. Chalmers Scholarship and Sylvan Green Awards
Steven Goodman
2018 (Portland) Annual Meeting
2018 (Portland) Annual Meeting
Curtis Meinert Lecture
Research reproducibility and research reform: lessons from clinical trials
Research reproducibility and research reform: lessons from clinical trials
Ted Karrison, PhD
2018 (Portland) Annual Meeting
2018 (Portland) Annual Meeting
Presidential Welcome
Welcome - 2017-18 SCT President
Welcome - 2017-18 SCT President
J. Michael Gaziano
2017 (Liverpool) Annual Meeting
2017 (Liverpool) Annual Meeting
Founders Lecture
The Million Veteran Program: A Modern Mega-Cohort within a Healthcare system Using Big Health Data to Improve Health Care
The Million Veteran Program: A Modern Mega-Cohort within a Healthcare system Using Big Health Data to Improve Health Care
Jerry Wolinsky
2017 (Liverpool) Annual Meeting
2017 (Liverpool) Annual Meeting
Trial of the Year Award
ORATORIO
ORATORIO
James J. Dignam
2017 (Liverpool) Annual Meeting
2017 (Liverpool) Annual Meeting
Award Presentation
Thomas C. Chalmers Scholarship and Sylvan Green Awards
Thomas C. Chalmers Scholarship and Sylvan Green Awards
Susan S. Ellenberg
2017 (Liverpool) Annual Meeting
2017 (Liverpool) Annual Meeting
Curtis Meinert Lecture
Clinical Trials in the Twenty-First Century: Ongoing Challenges and Emerging Issues
Clinical Trials in the Twenty-First Century: Ongoing Challenges and Emerging Issues
Will Meurer & Jon Nichols
2017 (Liverpool) Annual Meeting
2017 (Liverpool) Annual Meeting
Special Presentation
Opening Remarks, Program Scientific Committee Co-Chairs
Opening Remarks, Program Scientific Committee Co-Chairs
Susan Halabi
2017 (Liverpool) Annual Meeting
2017 (Liverpool) Annual Meeting
Fellows Presentation
Presentation of the Class of 2017 Fellows
Presentation of the Class of 2017 Fellows
Richard Stephens
2016 (Montreal) Annual Meeting
2016 (Montreal) Annual Meeting
Founders Lecture
Patients as Partners in Cancer Research
Patients as Partners in Cancer Research
LEAP Trial team
2016 (Montreal) Annual Meeting
2016 (Montreal) Annual Meeting
Trial of the Year Award
Learning Early About Peanut Allergy (LEAP)
Learning Early About Peanut Allergy (LEAP)
Denis Lacombe
2016 (Montreal) Annual Meeting
2016 (Montreal) Annual Meeting
Curtis Meinert Lecture
EOTRC (European Organisation for Research and Treatment of Cancer)
EOTRC (European Organisation for Research and Treatment of Cancer)
Mark Espeland
2016 (Montreal) Annual Meeting
2016 (Montreal) Annual Meeting
Fellows Presentation
Presentation of the Class of 2016 Fellows
Presentation of the Class of 2016 Fellows
Michael S. Lauer
2015 (Arlington) Annual Meeting
2015 (Arlington) Annual Meeting
Founders Lecture
A Future for Clinical Trials? An NIH Perspective
A Future for Clinical Trials? An NIH Perspective
Study Team
2015 (Arlington) Annual Meeting
2015 (Arlington) Annual Meeting
Trial of the Year Award
Mechanical versus Manual Chest Compression for Out-of-Hospital Cardiac Arrest (PARAMEDIC)
Mechanical versus Manual Chest Compression for Out-of-Hospital Cardiac Arrest (PARAMEDIC)
James D. Neaton
2015 (Arlington) Annual Meeting
2015 (Arlington) Annual Meeting
Curtis Meinert Lecture
International Trials and Tribulations
International Trials and Tribulations
Steve Goodman
2015 (Arlington) Annual Meeting
2015 (Arlington) Annual Meeting
Special Presentation
Remembering David Sackett
Remembering David Sackett
Cook et al
2015 (Arlington) Annual Meeting
2015 (Arlington) Annual Meeting
Special Presentation
Workshop - Conducting Valid Trials: the Critical (and Misunderstood) Roles of Randomization and Complete Follow-Up
Workshop - Conducting Valid Trials: the Critical (and Misunderstood) Roles of Randomization and Complete Follow-Up
Jennifer Gassman
2015 (Arlington) Annual Meeting
2015 (Arlington) Annual Meeting
Fellows Presentation
Presentation of the Class of 2015 Fellows
Presentation of the Class of 2015 Fellows
Christopher P. Austin
2014 (Philadelphia) Annual Meeting
2014 (Philadelphia) Annual Meeting
Founders Lecture
The National Center for Advancing Translational Sciences: Catalyzing Translational Innovation
The National Center for Advancing Translational Sciences: Catalyzing Translational Innovation
Daumit et al
2014 (Philadelphia) Annual Meeting
2014 (Philadelphia) Annual Meeting
Trial of the Year Award
The Randomized Trial of Achieving Healthy Lifestyles in Psychiatric Rehabilitation (ACHIEVE)
The Randomized Trial of Achieving Healthy Lifestyles in Psychiatric Rehabilitation (ACHIEVE)
Sargent/Goodman
2014 (Philadelphia) Annual Meeting
2014 (Philadelphia) Annual Meeting
Special Presentation
Recognition - Steve Goodman, Clinical Trials Journal Editor 2004-2013
Recognition - Steve Goodman, Clinical Trials Journal Editor 2004-2013
Peter Peduzzi
2014 (Philadelphia) Annual Meeting
2014 (Philadelphia) Annual Meeting
Fellows Presentation
Presentation of the Class of 2014 Fellows
Presentation of the Class of 2014 Fellows
Silbergleit et al
2013 (Boston) Annual Meeting
2013 (Boston) Annual Meeting
Trial of the Year Award
Rapid Anticonvulsant Medication Prior to Arrival Trial (RAMPART)
Rapid Anticonvulsant Medication Prior to Arrival Trial (RAMPART)
Richard Saitz
2013 (Boston) Annual Meeting
2013 (Boston) Annual Meeting
Founders Lecture
Challenges for Health Behavior Trials from Design to Practice: The Example of Unhealthy Alcohol Use
Challenges for Health Behavior Trials from Design to Practice: The Example of Unhealthy Alcohol Use
Paul Wakim
2013 (Boston) Annual Meeting
2013 (Boston) Annual Meeting
Special Presentation
Workshop - Practical Statistical Reasoning in Clinical Trials for Non-Statsticians (3) Trial Monitoring (Interim analyses & sample-size recalculation)
Workshop - Practical Statistical Reasoning in Clinical Trials for Non-Statsticians (3) Trial Monitoring (Interim analyses & sample-size recalculation)
Paul Wakim
2013 (Boston) Annual Meeting
2013 (Boston) Annual Meeting
Special Presentation
Workshop - Practical Statistical Reasoning in Clinical Trials for Non-Statsticians (5) Publication of Results
Workshop - Practical Statistical Reasoning in Clinical Trials for Non-Statsticians (5) Publication of Results
Michele Melia
2013 (Boston) Annual Meeting
2013 (Boston) Annual Meeting
Special Presentation
Workshop - Practical Statistical Reasoning in Clinical Trials for Non-Statsticians (4) Final Analysis & Subgroup Analysis (reject H0, p-value, correct, site-by-treatment interaction)
Workshop - Practical Statistical Reasoning in Clinical Trials for Non-Statsticians (4) Final Analysis & Subgroup Analysis (reject H0, p-value, correct, site-by-treatment interaction)
Paul Wakim
2013 (Boston) Annual Meeting
2013 (Boston) Annual Meeting
Special Presentation
Workshop - Practical Statistical Reasoning in Clinical Trials for Non-Statsticians (2) Analysis Plan (simple vs. complex, use of covariates, longitudinal models, handling missing data)
Workshop - Practical Statistical Reasoning in Clinical Trials for Non-Statsticians (2) Analysis Plan (simple vs. complex, use of covariates, longitudinal models, handling missing data)
Michele Melia
2013 (Boston) Annual Meeting
2013 (Boston) Annual Meeting
Special Presentation
Workshop - Practical Statistical Reasoning in Clinical Trials for Non-Statsticians (1) Overview of Trial Design (hypothesis testing, sample size, power)
Workshop - Practical Statistical Reasoning in Clinical Trials for Non-Statsticians (1) Overview of Trial Design (hypothesis testing, sample size, power)
Karthik Venkatakrishnan
2013 (Boston) Annual Meeting
2013 (Boston) Annual Meeting
Special Presentation
Workshop - Clinical Pharmacology and Pharmacometrics for Statisticians and Clinical Trialists (3) Drug-Drug Interactions and Pharmacogenomic Variation (Part 2 - Application in Therapuetics and Drug Development)
Workshop - Clinical Pharmacology and Pharmacometrics for Statisticians and Clinical Trialists (3) Drug-Drug Interactions and Pharmacogenomic Variation (Part 2 - Application in Therapuetics and Drug Development)
Karthik Venkatakrishnan
2013 (Boston) Annual Meeting
2013 (Boston) Annual Meeting
Special Presentation
Workshop - Clinical Pharmacology and Pharmacometrics for Statisticians and Clinical Trialists (2) Drug-Drug Interactions and Pharmacogenomic Variation (Part 1 - Illustrated Examples of Principles)
Workshop - Clinical Pharmacology and Pharmacometrics for Statisticians and Clinical Trialists (2) Drug-Drug Interactions and Pharmacogenomic Variation (Part 1 - Illustrated Examples of Principles)
Kevin Sweeney
2013 (Boston) Annual Meeting
2013 (Boston) Annual Meeting
Special Presentation
Workshop - Clinical Pharmacology and Pharmacometrics for Statisticians and Clinical Trialists (4) Principles of Pharmacometrics
Workshop - Clinical Pharmacology and Pharmacometrics for Statisticians and Clinical Trialists (4) Principles of Pharmacometrics
David Greenblatt
2013 (Boston) Annual Meeting
2013 (Boston) Annual Meeting
Special Presentation
Workshop - Clinical Pharmacology and Pharmacometrics for Statisticians and Clinical Trialists (1) Pharmacokenetics
Workshop - Clinical Pharmacology and Pharmacometrics for Statisticians and Clinical Trialists (1) Pharmacokenetics
Peter Peduzzi
2013 (Boston) Annual Meeting
2013 (Boston) Annual Meeting
Fellows Presentation
Presentation of the Class of 2013 Fellows
Presentation of the Class of 2013 Fellows
Atul Butte
2013 (Boston) Annual Meeting
2013 (Boston) Annual Meeting
Curtis Meinert Lecture
Transforming a Trillion Points of Data into Diagnostics, Therapeutics, and New Insights into Disease
Transforming a Trillion Points of Data into Diagnostics, Therapeutics, and New Insights into Disease
Dale Williams
2013 (Boston) Annual Meeting
2013 (Boston) Annual Meeting
Special Presentation
35 Years of SCT
35 Years of SCT
Jim Neaton
2012 (Miami) Annual Meeting
2012 (Miami) Annual Meeting
Special Presentation
Workshop - The Prevention and Treatment of Missing Data in Clinical Trials - Trial Stategies to Reduce the Frequency of Missing Data
Workshop - The Prevention and Treatment of Missing Data in Clinical Trials - Trial Stategies to Reduce the Frequency of Missing Data
Sue-Jane Wang
2012 (Miami) Annual Meeting
2012 (Miami) Annual Meeting
Special Presentation
Workshop - Biomarkers in Clinical Trials: General Principles for Study Design and Statistical Evaluation (1)-Overview of Biomarkers in Drug Development
Workshop - Biomarkers in Clinical Trials: General Principles for Study Design and Statistical Evaluation (1)-Overview of Biomarkers in Drug Development
Gene Pennello
2012 (Miami) Annual Meeting
2012 (Miami) Annual Meeting
Special Presentation
Workshop - Biomarkers in Clinical Trials: General Principles for Study Design and Statistical Evaluation (3)-Overview of Biomarkers in Device Development
Workshop - Biomarkers in Clinical Trials: General Principles for Study Design and Statistical Evaluation (3)-Overview of Biomarkers in Device Development
Geert Molenberghs
2012 (Miami) Annual Meeting
2012 (Miami) Annual Meeting
Special Presentation
Workshop - Biomarkers in Clinical Trials: General Principles for Study Design and Statistical Evaluation (2)-Overview of Surrogate Endpoint Evaluation in Clinic Studies
Workshop - Biomarkers in Clinical Trials: General Principles for Study Design and Statistical Evaluation (2)-Overview of Surrogate Endpoint Evaluation in Clinic Studies
Sumithra Mandrekar
2012 (Miami) Annual Meeting
2012 (Miami) Annual Meeting
Special Presentation
Workshop - Biomarkers in Clinical Trials: General Principles for Study Design and Statistical Evaluation (4)-Biomaker Trial Designs: Lessons from Real Trials
Workshop - Biomarkers in Clinical Trials: General Principles for Study Design and Statistical Evaluation (4)-Biomaker Trial Designs: Lessons from Real Trials
Larry Friedman
2012 (Miami) Annual Meeting
2012 (Miami) Annual Meeting
Trial of the Year Award
In Memory of Paul Meier & MOMS: Management of Myelomeningocele Study
In Memory of Paul Meier & MOMS: Management of Myelomeningocele Study
Wafaa El-Sadr
2012 (Miami) Annual Meeting
2012 (Miami) Annual Meeting
Curtis Meinert Lecture
Global HIV Prevention Trials
Global HIV Prevention Trials
John P.A. Ioannidis
2012 (Miami) Annual Meeting
2012 (Miami) Annual Meeting
Founders Lecture
Designing and Dissecting the Geometry of Randomized Evidence
Designing and Dissecting the Geometry of Randomized Evidence
John Lachin
2012 (Miami) Annual Meeting
2012 (Miami) Annual Meeting
Fellows Presentation
Presentation of the Class of 2012 Fellows
Presentation of the Class of 2012 Fellows
Yves Rosenberg
2011 (Vancouver) Annual Meeting
2011 (Vancouver) Annual Meeting
Special Presentation
Workshop - Essentials of Randomized Clinical Trials - (1) Introduction to Randomized Clinical Trials
Workshop - Essentials of Randomized Clinical Trials - (1) Introduction to Randomized Clinical Trials
Michele Melia
2011 (Vancouver) Annual Meeting
2011 (Vancouver) Annual Meeting
Special Presentation
Workshop - Essentials of Randomized Clinical Trials - (4) Treatment Allocation
Workshop - Essentials of Randomized Clinical Trials - (4) Treatment Allocation
Laura Lovato
2011 (Vancouver) Annual Meeting
2011 (Vancouver) Annual Meeting
Special Presentation
Workshop - Essentials of Randomized Clinical Trials - (2) Data Collection, Reporting, and Quality Control Issues
Workshop - Essentials of Randomized Clinical Trials - (2) Data Collection, Reporting, and Quality Control Issues
Susan Halabi
2011 (Vancouver) Annual Meeting
2011 (Vancouver) Annual Meeting
Special Presentation
Workshop - Essentials of Randomized Clinical Trials - (6) General Statistical Concepts
Workshop - Essentials of Randomized Clinical Trials - (6) General Statistical Concepts
Susan Halabi
2011 (Vancouver) Annual Meeting
2011 (Vancouver) Annual Meeting
Special Presentation
Workshop - Essentials of Randomized Clinical Trials - (5) Choice of Endpoints
Workshop - Essentials of Randomized Clinical Trials - (5) Choice of Endpoints
Dixie Ecklund
2011 (Vancouver) Annual Meeting
2011 (Vancouver) Annual Meeting
Special Presentation
Workshop - Essentials of Randomized Clinical Trials - (3) Project Management in Clinical Trials
Workshop - Essentials of Randomized Clinical Trials - (3) Project Management in Clinical Trials
Prasanta Tripathy
2011 (Vancouver) Annual Meeting
2011 (Vancouver) Annual Meeting
Trial of the Year Award
The Ekjut Trial in Jharkhand and Orissa
The Ekjut Trial in Jharkhand and Orissa
Johan Karlberg
2011 (Vancouver) Annual Meeting
2011 (Vancouver) Annual Meeting
Founders Lecture
Asian Clinical Trial Trends by Sponsor, Trial Phase, Disease Area, Country
Asian Clinical Trial Trends by Sponsor, Trial Phase, Disease Area, Country
Anushka Patel
2011 (Vancouver) Annual Meeting
2011 (Vancouver) Annual Meeting
Curtis Meinert Lecture
Crouching Tiger, Hidden Dragon: Clinical Trials in Asia
Crouching Tiger, Hidden Dragon: Clinical Trials in Asia
José Pinheiro
2010 (Baltimore) Annual Meeting
2010 (Baltimore) Annual Meeting
Special Presentation
Workshop: Adaptive Clinical Trials (2) Adaptive Dose-Ranging Designs and Methods
Workshop: Adaptive Clinical Trials (2) Adaptive Dose-Ranging Designs and Methods
Roger Lewis
2010 (Baltimore) Annual Meeting
2010 (Baltimore) Annual Meeting
Special Presentation
Workshop: Adaptive Clinical Trials (1) Short Course
Workshop: Adaptive Clinical Trials (1) Short Course
Jason Connor
2010 (Baltimore) Annual Meeting
2010 (Baltimore) Annual Meeting
Special Presentation
Workshop: Adaptive Clinical Trials (3) Bayesian Adaptive Designs for Clinical Trials
Workshop: Adaptive Clinical Trials (3) Bayesian Adaptive Designs for Clinical Trials
Joshua Sharfstein
2010 (Baltimore) Annual Meeting
2010 (Baltimore) Annual Meeting
Curtis Meinert Lecture
FDA, Clinical Trials, and Public Health
FDA, Clinical Trials, and Public Health
Richard Schilsky
2010 (Baltimore) Annual Meeting
2010 (Baltimore) Annual Meeting
Founders Lecture
Publicly Funded Clinical Trials in the Era of Comparative Research Effectiveness
Publicly Funded Clinical Trials in the Era of Comparative Research Effectiveness
2010 (Baltimore) Annual Meeting
Fellows Presentation
Presentation of the Class of 2010 Fellows
Presentation of the Class of 2010 Fellows